PHI with Tick-borne encephalitis vaccination
How does this condition affect your private health insurance?
FSM-Impfung, or Tick-borne Encephalitis Vaccination, is a medical procedure to prevent the actual TBE disease. However, individuals may experience transient reactions that mimic a temporary illness. Common symptoms include localized pain, redness, or swelling at the injection site. Some individuals might also develop mild systemic effects like low-grade fever, headache, muscle aches, or fatigue. These reactions typically onset within 24-48 hours post-administration and usually resolve spontaneously within one to two days. Severe allergic responses are exceedingly rare. The primary purpose of FSM-Impfung is to build robust immunity against the TBE virus, thereby averting the serious neurological complications of the actual disease.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
1-2 days
Duration of Illness (Lifetime)
Transient, not chronic; resolves after each occurrence (vaccine dose)
Cost of Treatment (Initial)
Minimal, typically self-managed with over-the-counter pain relief if needed
Cost of Treatment (Lifetime)
Minimal, related to symptomatic relief for rare and mild adverse events
Mortality Rate
Extremely low (less than 1 in a million, primarily from severe anaphylactic reaction)
Risk of Secondary Damages
Extremely low (e.g., localized inflammation, nerve damage from injection site, but exceedingly rare)
Probability of Full Recovery
Nearly 100% for typical transient reactions; complete recovery is the norm
Underlying Disease Risk
Negligible for common reactions; pre-existing conditions may influence rare severe reactions but are not caused by it